Antibodies against the erythroferrone N-terminal domain prevent hepcidin suppression and ameliorate murine thalassemia
Erythroferrone (ERFE) is produced by erythroblasts in response to erythropoietin (EPO) and acts in the liver to prevent hepcidin stimulation by BMP6. Hepcidin suppression allows for the mobilization of iron to the bone marrow for the production of red blood cells. Aberrantly high circulating ERFE in...
Κύριοι συγγραφείς: | Arezes, J, Foy, N, McHugh, K, Quinkert, D, Benard, S, Sawant, A, Frost, J, Armitage, A, Pasricha, S, Lim, P, Tam, M, Lavallie, E, Pittman, D, Cunningham, O, Lambert, M, Murphy, J, Draper, S, Jasuja, R, Drakesmith, A |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
American Society of Hematology
2020
|
Παρόμοια τεκμήρια
-
Erythroferrone inhibits the induction of hepcidin by BMP6
ανά: Arezes, J, κ.ά.
Έκδοση: (2018) -
Is the Role of Hepcidin and Erythroferrone in the Pathogenesis of Beta Thalassemia the Key to Developing Novel Treatment Strategies?
ανά: Tsz Yuen Au, κ.ά.
Έκδοση: (2022-09-01) -
Regulation of hepcidin by erythropoiesis: The story so far.
ανά: Pasricha, S, κ.ά.
Έκδοση: (2016) -
Erythroferrone: An Erythroid Regulator of Hepcidin and Iron Metabolism
ανά: Richard Coffey, κ.ά.
Έκδοση: (2018-04-01) -
Erythroferrone and hepcidin levels in children with iron deficiency anemia
ανά: Ramazan Dulkadir, κ.ά.
Έκδοση: (2024-04-01)